Brief: Keros Therapeutics Announces Tropos Topline Data And Corporate Restructuring
29/05/2025 13:10
May 29 (Reuters) - Keros Therapeutics Inc KROS.O: KEROS THERAPEUTICS ANNOUNCES TROPOS TOPLINE DATA AND CORPORATE RESTRUCTURING KEROS THERAPEUTICS INC - TO REDUCE HEADCOUNT BY ABOUT 45% KEROS THERAPEUTICS INC - DISCONTINUES DEVELOPMENT OF CIBOTERCEPT IN PAH KEROS THERAPEUTICS INC - EXPECTS ANNUALIZED COST SAVINGS OF ABOUT $17 MILLION Source text: ID:nGNX7jRWVZ Further company coverage: KROS.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Keros Therapeutics
See all newsBrief: Keros Therapeutics May Offer Up To $350 Million Of Securities - SEC Filing
Keros Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Keros Therapeutics Q2 net loss narrows on lower expenses
Brief: Keros Therapeutics - Keith Regnante Resigns As CFO
Keros Therapeutics posts Q1 net loss as license revenue drops